Interaction of the cyclin-dependent kinase inhibitor p21 with PCNA: A link between cell cycle and DNA repair;Interaction entre l'inhibiteur des kinases dependantes des cyclines p21 et le PCNA: Un lien entre le cycle cellulaire, la replication et la reparation de l'ADN

Medecine/Sciences

Volumn 13, Issue 11, 1997, Pages 1259-1265

  Cayrol, Corinne ^b   Ducommun, Bernard ^a,b  

^a Biologie Cellulaire   (France)

^b UNIVERSITÉ PAUL SABATIER   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR; CYCLINE; DNA POLYMERASE; PROTEIN P21; PROTEIN P53;

AMINO TERMINAL SEQUENCE; BASE MISPAIRING; BINDING SITE; CARBOXY TERMINAL SEQUENCE; CELL CYCLE; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CELL PROLIFERATION; CONTROLLED STUDY; DNA DAMAGE; DNA REPAIR; DNA REPLICATION; ENZYME INHIBITION; GROWTH DISORDER; HUMAN; REVIEW;

EID: 0030717645     PISSN: 07670974     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (33)

1. Wolowiec D, Ffrench M. Kinases dépendantes des cyclines: rôle biologique et implications dans la pathologie humaine. Med Sci 1996; 12: 165-73.
2. Darbon J, Fesquet D, Cavadore J. De nouveaux régulateurs du cycle cellulaire: les protéines modulatrices des complexes Cdk-cyclines. Med Sci 1995; 11 : 349-56.
3. Shiviji MKK, Kenny MK, Wood RD. Proliferating cell nuclear antigen is required for DNA excision repair synthesis. Cell 1992; 69: 367-74.
4. Russo AA, Jeffrey PD, Patten AK, Massagué J, Pavletich NP. Crystal structure of the p27Kip1 cyclin-dependent-kinase inhibitor bound to the cyclinA-Cdk2 complex. Nature 1996; 382 : 325-30.
5. Elledge SJ, Winston J, Harper W. A question of balance: the role of cyclin-kinase inhibitors in development and tumorogenesis. Trends Cell Biol 1996; 6: 388-92.
6. Sherr CJ, Roberts JR. Inhibitors of mammalian G1 cyclin-dependant kinases. Genes Dev 1995b; 9: 1149-63.
7. Luo Y, Hurwitz J, Massagué J. Cell-cycle inhibition by independent Cdk and PCNA binding domains in p21. Nature 1995; 375: 159-61
8. Fotedar R, Fitzgerald P, Rousselle T, Cannella D, Dorée M, Messier H, Fotedar A. p21 contains independent binding sites for cyclin and cdk2: both sites are required to inhibit cdk2 kinase activity. Oncogene 1996; 12 : 2155-64.
9. Yang ZY, Perkins ND, Ohno T, Nabel EG, Nabel GJ. The p21 cyclin-dependent kinase inhibitor suppresses tumorigenicity in vivo. Nature Med 1995; 1 : 1052-6.
10. Deng C, Zhang P, Harper JW, Elledge SJ, Leder P. Mice lacking p21Cip1/WAF1 undergo normal development, but are defective in G1 checkpoint control. Cell 1995; 82 : 675-84.
11. El-Deiry W, Tokino T, Velculescu V, Levy D, Parsons R, Trent J, Lin D, Mercer W, Kinzler K, Volgestein B. WAF1, a potential mediator of p53 tumor suppression. Cell 1993; 75 : 817-25.
12. Dulic V, Kaufmann W, Wilson S, Tlsty T, Lees E, Wade Harper J, Elledge S, Reed S. p53-dependent inhibition of cyclin-dependent kinase activities in human fibroblasts during radiation-induced G1 arrest. Cell 1994; 76 : 1013-23.
13. Brugarolas J, Chandrasekaran C, Gordon JI, Beach D, Jacks T, Hannon GJ. Radiation-induced cell cycle arrest compromised by p21 deficiency. Nature 1995; 377 : 552-7.
14. Halevy O, Novitch BG, Spicer DB, Skapek SX, Rhee J, Hannon GJ, Beach D, Lassar AB. Correlation of terminal cell cycle arrest of skeletal muscle with induction of p21 by MyoD. Science 1995; 267 : 1018-21.
15. Chin YE, Kitagawa M, Su WCE, You ZH, Iwamoto Y, Fu XY. Cell growth arrest and induction of cyclin-dependent kinase inhibitor p21Cip1 mediated by stat1. Science 1996; 272 : 719-21.
16. Liu M, Lee MH, Cohen M, Bommakanti M, Freedman LP. Transcriptional activation of the Cdk inhibitor p21 by vitamin D3 leads to the induced differentiation of the myelomonocytic cell line U937. Genes Dev 1096; 10 : 142-53.
17. Datto MB, Yu Y, Wang XF. Functional analysis of the transforming growth factor β responsive element in the WAF1/Cip1/p21 promoter. J Biol Chem 1995; 270 : 28623-8.
18. Goubin F, Ducommun B. Identification of binding domains on the p21Cip1 cyclin-dependent kinase inhibitor. Oncogene 1995; 10 : 2281-7.
19. Warbrick E, Lane DP, Glover DM, Cox LS. A small peptide inhibitor of DNA replication defines the site of interaction between the cyclin-dependent kinase inhibitor p21Waf1 and proliferating cell nuclear antigen. Curr Biol 1995; 5 : 275-82.
20. Gulbis JM, Kelman Z, Hurwitz J, O'Donnell M, Kuriyan J. Structure of the C-terminal region of p21Cip1/Waf1 complexed with human PCNA. Cell 1996; 87 : 297-306.
21. Knibiehler M, Goubin F, Escalas N, Jonsson ZO, Mazarguil H, Hubscher U, Ducommun B. Interaction studies between the p21Cip1/Waf1 cyclin-dependent kinase inhibitor and proliferating cell nuclear antigen (PCNA) by surface plasmon resonance. FEBS Lett 1996; 391 : 66-70.
22. Waga S, Hannon GJ, Beach D, Stillman B. The p21 inhibitor of cyclin-dependent kinases controls DNA replication by interaction with PCNA. Nature 1994; 369 : 574-8.
23. Flores-Rozas H, Kelman Z, Dean F, Pan ZQ, Wade Harper J, Elledge S, O'Donnell M, Hurwitz J. Cdk-interacting protein 1 directly binds with proliferating cell nuclear antigen and inhibits replication catalyzed by the DNA polymerase delta holoenzyme. Proc Natl Acad Sci USA 1994; 91 : 8655-9.
24. Podust VN, Podust LM, Goubin F, Ducommun B, Hubscher U. Mechanism of inhibition of PCNA dependent DNA synthesis by the p21 cdk-interacting protein 1. Biochemistry 1995; 34 : 8869-75.
25. Li R, Waga S, Hannon G, Beach D, Stillman B. Differential effects by the p21 Cdk inhibitor on PCNA dependent DNA replication and repair. Nature 1994; 371 : 539-42.
26. cip1/waf1 disrupts the recruitment of human fen 1 by proliferating - cell nuclear antigen into the DNA replication complex. Proc Natl Acad Sci USA 1996; 93: 11597-602.
27. Strausfeld UP, Howell M, Rempel R, Maller JL, Hunt T, Blow JJ. Cip1 blocks the initiation of DNA replication in Xenopus extracts by inhibition of cyclin-dependent kinases. Curr Biol 1994; 4 : 876-83.
28. Xiong Y, Zhang H, Beach D. D-type cyclin associate with multiple protein kinases and the DNA replication and repair factor PCNA. Cell 1992; 71 : 505-14.
29. + cell cycle checkpoint pathway. Mol Biol Cell 1996; 7 : 651-61.
30. 2 cell cycle arrest in p53-deficient cells. Oncogene 1997 (sous presse).
31. Li R, Hannon GJ, Beach D, Stillman B. Subcellular distribution of p21 and PCNA in normal and repair deficient cells following DNA damage. Curr Biol 1996; 6 : 189-99.
32. -/- human cancer cells. Cancer Res 1996; 56 : 2250-5.
33. Umar A, Buermeyer AB, Simon JA, Thomas DC, Clark AB, Liskay RM, Kunkel TA. Requirement for PCNA in DNA mismatch repair at step preceding DNA resynthesis. Cell 1996; 87 : 65-73.